We are live on ! Find out more
CVAC

CureVac
CVAC

Delisted

CVAC was delisted on the 5th of January, 2026.

Back to rankings

90 hedge funds and large institutions have $93.4M invested in CureVac in 2023 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 24 increasing their positions, 26 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

76% more call options, than puts

Call options by funds: $2.88M | Put options by funds: $1.64M

47% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 15

7% more funds holding

Funds holding: 84 → 90 (+6)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

8% less repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 26

5.14% less ownership

Funds ownership: 15.06% → 9.92% (-5.1%)

59% less capital invested

Capital invested by funds: $230M → $93.4M (-$137M)

Holders
90
Holders Change
+6
Holders Change %
+7.14%
% of All Funds
0%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0%
New
22
Increased
24
Reduced
26
Closed
15
Calls
$2.88M
Puts
$1.64M
Net Calls
+$1.25M
Net Calls Change
-$3.57M

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$4.99M
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$2.17M
3
Walleye Capital
Walleye Capital
New York
+$2.01M
4
Morgan Stanley
Morgan Stanley
New York
+$1.79M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$1.51M

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$42.6M
2
APM
Avidity Partners Management
Texas
-$21.3M
3
Citadel Advisors
Citadel Advisors
Florida
-$11.8M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$4.68M
5
TD Asset Management
TD Asset Management
Ontario, Canada
-$1.43M

CVAC Hedge Fund Activity: Q4 2023 in Review

90 institutional investors reported a position in CureVac (CVAC) for Q4 2023, worth a combined $93.4M — down 59% from $230M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new CVAC positions and 15 closed out — a net gain of 7 holders — while 24 added to existing stakes and 26 trimmed.

The largest buyer was Millennium Management, adding an estimated $4.99M. The largest seller was RA Capital Management, cutting an estimated $42.6M.

  • 90 institutional investors held CureVac (CVAC) as of Q4 2023, up from 84 in Q3 2023.
  • Funds reported $93.4M of CureVac stock for Q4 2023, down 59% quarter-over-quarter.
  • 22 funds opened new CureVac positions in Q4 2023 and 15 closed out, a net change of +7 holders.
  • The largest CureVac buyer in Q4 2023 was Millennium Management, an estimated $4.99M added.
  • The largest CureVac seller in Q4 2023 was RA Capital Management, an estimated $42.6M sold.

Based on aggregated 13F filings for Q4 2023.